The Sanford Guide 1.3.1

The Sanford Guide 1.3.1

User Rating: Fair (0.00/5)

Antimicrobial Therapy, Inc|More programs
iOS 4.0 or later
March 19th, 2012

See full specifications

Download Now

6.10 MB|0 downloads

The Sanford Guide 1.3.1 Description

The Sanford Guide 1.3.1 is described as a handy, smart and effective resource for healthcare professionals who care for patients with infectious diseases. The Sanford Guide to Antimicrobial Therapy 2011 application provides fast, convenient access to critical information on treatment of infectious diseases, for timely, effective decisions at the point of care.

Always a pocket guide, still a pocket guide. Portability has been a hallmark of The Sanford Guide for over 40 years. The Sanford Guide to Antimicrobial Therapy 2011 application extends that portability to iOS4 devices: iPhone, iPod Touch and iPad. The most trusted infectious diseases treatment resource in print now presents the same comprehensive, treatment- focused coverage of infectious diseases and clinical conditions, anti-infective drug information, therapeutic adjuncts and comparative spectra of activity in a clean, uncluttered, device-optimized interface. Based on the Sanford Guide Web Edition, the application features expanded coverage of topics compared to the print edition. 

Other than for the initial download and to receive updates, the application may be used fully without the need for connectivity. Maximum screen space is devoted to the display of content by limiting buttons to those considered to be most essential: Home, Back and Search. All buttons are located on the application menu bar. The Index is activated by the search button on the application menu bar. The same button also hides the keyboard for full screen display of Index topics. For more about the application and the Sanford Guide, use the Info button on the launch screen. 

Content queries are begun on the launch screen using a searchable Index or four Rapid Reference categories. Diseases and Clinical Conditions are organized by type (bacterial, fungal, mycobacterial, parasitic and viral). Bacterial diseases are further organized by site of infection and organism. Drug Information is similarly organized by type. Therapeutic Adjuncts include post-exposure antimicrobial prophylaxis (e.g., hepatitis, HIV, rabies), as well as preventative prophylaxis for surgical procedures and post-transplants. Comparison Tables include activity spectra tables for bacteria, fungi and viruses. These tables are color-coded for ease of use. 

Extensive internal links provide efficient navigation to related content. For instance, drug regimens on disease pages are linked to corresponding pages for each drug containing comprehensive information on usage, dosing, adverse effects, activity, pharmacology, pharmacodynamics and drug-drug interactions. Broad topics such as meningitis and pneumonia include Overview pages with an outline and links to all sub-topics for that disease. Literature references, e.g., PubMed abstracts and other resources, are accessible when you have an Internet connection. 

  • This update includes 2012 U.S. immunization schedules for adults, children and adolescents, content revisions and corrections.
  • This update reflects the remainder of major content update in conjunction with revisions to the print edition of The Sanford Guide to Antimicrobial Therapy for 2012.
  • Greatly expanded discussion and coverage of treatment options on bacterial organism pages. Organism names have been updated based on recent changes in nomenclature.
  • Drug information pages contain more comprehensive discussion of usage and regimens for specific diseases and clinical conditions, e.g., vancomycin, and class-wide information can be found on Overview pages, e.g., fluoroquinolones.
  • Providing some useful new tools with this update. Calculators for creatinine clearance, ideal body weight, body mass index and conversions are embedded in drug pages and in the Renal Dose Adjustment comparison table (iPad). The calculators may also be accessed from the main menu under Tables/Tools.
  • Resistance to antibacterial agents is increasing at an alarming pace. Materials on management of resistant gram-positives, including MRSA, and multi-drug resistant aerobic gram-negative bacilli, such as E. coli, have been extensively updated and expanded. Despite years of availability, the Polypeptide drugs: Polymyxin B and Polymyxin E (Colistin) are becoming more important options for treatment of gram-negative infections. Expanded discussion and new dose regimens for these drugs is presented.
  • There is increasing clinical application of continuous, or prolonged, infusion of antibacterials for those drugs where optimal efficacy correlates with time above the MIC of the target bacteria: cefepime, ceftazidime, doripenem, meropenem, piperacillin-tazobactam. Suggested regimens are included on relevant drug pages and summarized in the Continuous/Prolonged Infusion table (Tables/Tools in the Main Menu).
  • New once-weekly dosing combination therapy for high risk, latent M. Tuberculosis is included.
  • Hepatitis C (HCV) infects over 175 million people worldwide. Two new protease inhibitors, boceprevir and telaprevir, were approved in 2011 for treatment of HCV. Many more new drugs are in various stages of development in early 2012.
  • Antiretroviral therapy options continue to expand with the approval of new drugs, such as rilpivirine, and new combination formulations of ARV drugs, such as Complera.
  • A newly approved macrolide, fidaxomicin, is included as an option for treatment of moderate to severe C. difficille toxin-mediated diarrhea.
  • As always, references to current best evidence are cited throughout and linked to the PubMed database and other resources.
  • App indexing has been augmented based on ongoing review and user feedback.
  • Compatible with iPhone, iPod touch, and iPad.
  • Requires iOS 4.0 or later.
Download The Sanford Guide 1.3.1
Copyright The Sanford Guide 1.3.1

The Sanford Guide 1.3.1 Screenshots

Download The Sanford Guide 1.3.1
Other Soft Of Antimicrobial Therapy, Inc
Join the Softwareweb
By clicking "Create my account", you are indicating that you have read and accept the terms and conditions.

You can also sign in using :   If you are an author, Click here to register.
Log in to Softwareweb
Forgot your password?
Sign in with   
Password assistance

To receive your password, enter the e-mail address for your account below.

Join the Submit Software

This information will not be published on Softwareweb. It is only used for notification services.

By clicking "Create my account", you are indicating that you have read and accept the terms and conditions.


0 of 200 characters.